Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.9 HKD | -4.06% | -5.31% | -50.00% |
May. 02 | Gaush Meditech Swings to Profit in 2023 | MT |
Apr. 23 | Gaush Meditech Ltd Announces Change in Joint Company Secretary | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 49% by 2026.
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 11.67 for the current year and 9.26 for next year, earnings multiples are highly attractive compared with competitors.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-50.00% | 358M | - | ||
-5.27% | 9.18B | B+ | ||
-3.36% | 1.4B | D | ||
-9.03% | 1.34B | B+ | ||
-15.29% | 1.08B | - | ||
-20.70% | 832M | - | - | |
-1.15% | 463M | - | ||
+1.81% | 435M | - | - | |
-24.35% | 335M | - | - | |
-3.26% | 211M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2407 Stock
- Ratings Gaush Meditech Ltd